Par Drugs and Chemicals Ltd
NSE:PAR
Par Drugs and Chemicals Ltd
NSE:PAR
Price:
98.65
INR
-3.38%
Market Closed
Market Cap:
₹1.2B
Income Statement
Earnings Waterfall
Par Drugs and Chemicals Ltd
Par Drugs and Chemicals Ltd
Income Statement
Par Drugs and Chemicals Ltd
Par Drugs and Chemicals Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
751
N/A
|
821
+9%
|
873
+6%
|
933
+7%
|
957
+3%
|
952
-1%
|
962
+1%
|
973
+1%
|
725
-26%
|
813
+12%
|
786
-3%
|
1 010
+28%
|
1 044
+3%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(288)
|
(335)
|
(371)
|
(409)
|
(664)
|
(392)
|
(378)
|
(354)
|
(244)
|
(275)
|
(284)
|
(678)
|
(420)
|
|
| Gross Profit |
463
N/A
|
486
+5%
|
502
+3%
|
524
+4%
|
293
-44%
|
560
+91%
|
585
+4%
|
619
+6%
|
481
-22%
|
539
+12%
|
503
-7%
|
628
+25%
|
624
-1%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(333)
|
(360)
|
(358)
|
(383)
|
(144)
|
(407)
|
(416)
|
(432)
|
(339)
|
(357)
|
(360)
|
(173)
|
(473)
|
|
| Selling, General & Administrative |
(41)
|
(42)
|
(42)
|
(46)
|
(111)
|
(51)
|
(52)
|
(53)
|
(39)
|
(41)
|
(40)
|
(137)
|
(60)
|
|
| Depreciation & Amortization |
(33)
|
(32)
|
(33)
|
(33)
|
(32)
|
(33)
|
(33)
|
(34)
|
(26)
|
(27)
|
(27)
|
(36)
|
(36)
|
|
| Other Operating Expenses |
(259)
|
(286)
|
(283)
|
(305)
|
(0)
|
(323)
|
(332)
|
(346)
|
(274)
|
(289)
|
(292)
|
0
|
(375)
|
|
| Operating Income |
130
N/A
|
126
-3%
|
144
+14%
|
141
-2%
|
150
+6%
|
153
+2%
|
168
+10%
|
187
+11%
|
142
-24%
|
182
+28%
|
143
-21%
|
159
+11%
|
152
-4%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
(4)
|
(5)
|
(3)
|
(2)
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
3
|
3
|
3
|
(1)
|
1
|
1
|
3
|
4
|
13
|
13
|
21
|
39
|
|
| Pre-Tax Income |
127
N/A
|
124
-2%
|
144
+16%
|
142
-2%
|
151
+6%
|
153
+2%
|
169
+10%
|
189
+12%
|
145
-23%
|
195
+34%
|
157
-20%
|
179
+14%
|
191
+7%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
(35)
|
(34)
|
(39)
|
(39)
|
(37)
|
(38)
|
(42)
|
(47)
|
(36)
|
(49)
|
(39)
|
(46)
|
(48)
|
|
| Income from Continuing Operations |
92
|
91
|
106
|
103
|
113
|
115
|
127
|
142
|
108
|
145
|
117
|
134
|
142
|
|
| Net Income (Common) |
92
N/A
|
91
-2%
|
106
+17%
|
103
-2%
|
113
+10%
|
115
+2%
|
127
+10%
|
142
+12%
|
108
-24%
|
145
+34%
|
117
-20%
|
134
+15%
|
142
+6%
|
|
| EPS (Diluted) |
7.49
N/A
|
7.35
-2%
|
8.58
+17%
|
8.38
-2%
|
9.21
+10%
|
9.36
+2%
|
10.3
+10%
|
11.56
+12%
|
9.01
-22%
|
12.1
+34%
|
9.73
-20%
|
11.16
+15%
|
11.81
+6%
|
|
Switch to:
Switch to:
See Also
Discover More
